Skip Navigation


Carcinogenesis Advance Access originally published online on March 28, 2003
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
24/5/991    most recent
bgg047v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (18)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Jernström, H.
Right arrow Articles by Narod, S.A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jernström, H.
Right arrow Articles by Narod, S.A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol. 24, No. 5, 991-1005, May 2003
© 2003 Oxford University Press


CARCINOGENESIS

Predictors of the plasma ratio of 2-hydroxyestrone to 16{alpha}-hydroxyestrone among pre-menopausal, nulliparous women from four ethnic groups

H. Jernström, T.L. Klug1, D.W. Sepkovic2, H.L. Bradlow3 and S.A. Narod3,4

The Jubileum Institute, Department of Oncology, Lund University Hospital, Sweden
1 Immuna Care Corporation, Bethlehem, PA, USA
2 The David and Alice Jurist Institute for Research, Hackensack University Medical Center, 30 Prospect Avenue, Hackensack, NJ and Department of Medicine, University of Medicine and Dentistry of New Jersey, Newark, NJ, USA
3 Centre for Research in Women's Health, Sunnybrook and Women's College Hospital, 790 Bay Street 7th Floor, Toronto, Ontario M5G 1N8, Canada

4 To whom correspondence should be addressed Email: steven.narod{at}swchsc.on.ca

Studies of circulating estrogen levels in relation to pre-menopausal breast cancer risk have yielded inconsistent results. Various estrogen metabolites might affect the risk differently. Estradiol metabolism occurs primarily via two mutually exclusive pathways, yielding 2-hydroxyestrone (2-OHE) and 16{alpha}-hydroxyestrone (16{alpha}-OHE). Most, but not all, studies have found that a relatively high 2-OHE/16{alpha}-OHE ratio is associated with a low breast cancer risk. Our objective was to determine if the 2-OHE/16{alpha}-OHE ratio in plasma correlates with suspected breast cancer risk factors and other lifestyle factors, such as ethnicity, body size, age at menarche, oral contraceptive use, smoking, vegetarian diet, coffee and alcohol consumption in 513 nulliparous women, aged 17–35. Oral contraceptive users had significantly lower 2-OHE/16{alpha}-OHE ratios than pill non-users (P = 10-21). Among women who were not using oral contraceptives, the median 2-OHE/16{alpha}-OHE ratio in plasma was similar for white, black, Indian/Pakistani and Asian women, after adjustment for age and menstrual cycle phase. Among oral contraceptive users, Asian women had significantly lower 2-OHE/16{alpha}-OHE ratios than white women, and this result remained after adjustment for age and day of menstrual cycle. Daily coffee consumption was significantly positively correlated with 2-OHE/16{alpha}-OHE ratios (rs = 0.18, P = 0.002) only among pill non-users. Our findings suggest that the plasma 2-OHE/16{alpha}-OHE ratio is associated with constitutional factors and with modifiable lifestyle factors. The reported elevated risk of early onset breast cancer among young oral contraceptive users could be mediated in part through altered estrogen metabolism induced by synthetic estrogens and progestins.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
E. Bageman, C. Ingvar, C. Rose, and H. Jernstrom
Coffee Consumption and CYP1A2*1F Genotype Modify Age at Breast Cancer Diagnosis and Estrogen Receptor Status
Cancer Epidemiol. Biomarkers Prev., April 1, 2008; 17(4): 895 - 901.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J. Kotsopoulos, P. Ghadirian, A. El-Sohemy, H. T. Lynch, C. Snyder, M. Daly, S. Domchek, S. Randall, B. Karlan, P. Zhang, et al.
The CYP1A2 Genotype Modifies the Association Between Coffee Consumption and Breast Cancer Risk Among BRCA1 Mutation Carriers
Cancer Epidemiol. Biomarkers Prev., May 1, 2007; 16(5): 912 - 916.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
K. L. Campbell, K. C. Westerlind, V. J. Harber, G. J. Bell, J. R. Mackey, and K. S. Courneya
Effects of Aerobic Exercise Training on Estrogen Metabolism in Premenopausal Women: A Randomized Controlled Trial
Cancer Epidemiol. Biomarkers Prev., April 1, 2007; 16(4): 731 - 739.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
M. R. Sowers, S. Crawford, D. S. McConnell, J. F. Randolph Jr., E. B. Gold, M. K. Wilkin, and B. Lasley
Selected Diet and Lifestyle Factors Are Associated with Estrogen Metabolites in a Multiracial/Ethnic Population of Women
J. Nutr., June 1, 2006; 136(6): 1588 - 1595.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
J. A. Baker, G. P. Beehler, A. C. Sawant, V. Jayaprakash, S. E. McCann, and K. B. Moysich
Consumption of Coffee, but Not Black Tea, Is Associated with Decreased Risk of Premenopausal Breast Cancer
J. Nutr., January 1, 2006; 136(1): 166 - 171.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
R. T. Falk, T. R. Fears, X. Xu, R. N. Hoover, M. C. Pike, A. H. Wu, A. M.Y. Nomura, L. N. Kolonel, D. W. West, D. W. Sepkovic, et al.
Urinary Estrogen Metabolites and Their Ratio among Asian American Women
Cancer Epidemiol. Biomarkers Prev., January 1, 2005; 14(1): 221 - 226.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.